Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH Q4 2026 Annual earnings

Reported May 13, 2026 · After market close

Revenue$281.6MMiss by $12.0M
EPS$1.23Miss by $0.16
Revenue estimate$293.6M
EPS estimate$1.39

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$249.7M
EPS estimate$0.89

Financials

Q4 2026

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$2.39B-36.4%
Enterprise value$3.37B-27.7%
P/E12.6×-5.1×
P/S2.2×-1.2×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Segments

By product

See full
Gastrointestinal$68.4M-0.8%
Women's Health$57.0M-10.6%
Eye & Ear Care$37.9M-19.0%
Dermatologicals$30.5M+4.8%
Analgesics$28.2M-6.5%

By segment

See full
North American OTC Healthcare$234.5M-5.8%
International OTC Healthcare$47.1M-1.0%

Versus estimates

Revenue

Q4 2026$281.6MMiss by $12.0M
Q3 2026$283.4MBeat by $1.2MQ2 2026$274.1MMiss by $20.0MQ1 2026$249.5MMiss by $25.5MQ4 2025$296.8MBeat by $26.3MQ3 2025$290.3MBeat by $510.6K

Diluted EPS

Q4 2026$1.23Miss by $0.16
Q3 2026$1.14Miss by $0.02Q2 2026$1.07Beat by $0.10Q1 2026$0.95Miss by $0.06Q4 2025$1.32Beat by $0.02Q3 2025$1.22Beat by $0.06

Ask the moment Prestige Consumer Healthcare reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Prestige Consumer Healthcare report Q4 2026 earnings?
Prestige Consumer Healthcare (PBH) reported Q4 2026 earnings on May 13, 2026 after market close.
What were Prestige Consumer Healthcare's Q4 2026 revenue and EPS?
Prestige Consumer Healthcare reported revenue of $281.6M and eps of $1.23 for Q4 2026.
Did Prestige Consumer Healthcare beat estimates in Q4 2026?
Revenue missed the consensus estimate of $293.6M by $12.0M. EPS missed the consensus estimate of $1.39 by $0.16.
How did Prestige Consumer Healthcare's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 5.1% from $296.8M a year earlier and eps declined 6.8% from $1.32.
Where can I find Prestige Consumer Healthcare's Q4 2026 SEC filings?
You can read the 8-K earnings release (0001295947-26-000013) and the 10-K periodic report (0001295947-26-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.